JP2022549292A5 - - Google Patents

Info

Publication number
JP2022549292A5
JP2022549292A5 JP2022518356A JP2022518356A JP2022549292A5 JP 2022549292 A5 JP2022549292 A5 JP 2022549292A5 JP 2022518356 A JP2022518356 A JP 2022518356A JP 2022518356 A JP2022518356 A JP 2022518356A JP 2022549292 A5 JP2022549292 A5 JP 2022549292A5
Authority
JP
Japan
Prior art keywords
antigen
carbohydrate
vaccine composition
peptide
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022518356A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022549292A (ja
JP7734654B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/051253 external-priority patent/WO2021056098A1/en
Publication of JP2022549292A publication Critical patent/JP2022549292A/ja
Publication of JP2022549292A5 publication Critical patent/JP2022549292A5/ja
Application granted granted Critical
Publication of JP7734654B2 publication Critical patent/JP7734654B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022518356A 2019-09-23 2020-09-18 ワクチンおよび治療ツールとしてのネオ複合糖質 Active JP7734654B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962904312P 2019-09-23 2019-09-23
US62/904,312 2019-09-23
US202063060452P 2020-08-03 2020-08-03
US63/060,452 2020-08-03
PCT/CA2020/051253 WO2021056098A1 (en) 2019-09-23 2020-09-18 Neoglycoconjugates as vaccines and therapeutic tools

Publications (3)

Publication Number Publication Date
JP2022549292A JP2022549292A (ja) 2022-11-24
JP2022549292A5 true JP2022549292A5 (https=) 2024-04-26
JP7734654B2 JP7734654B2 (ja) 2025-09-05

Family

ID=74880385

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022518356A Active JP7734654B2 (ja) 2019-09-23 2020-09-18 ワクチンおよび治療ツールとしてのネオ複合糖質

Country Status (8)

Country Link
US (3) US10973910B1 (https=)
EP (2) EP4034159A4 (https=)
JP (1) JP7734654B2 (https=)
KR (1) KR20220115556A (https=)
CN (2) CN115003330A (https=)
AU (1) AU2020353390A1 (https=)
IL (1) IL291601B2 (https=)
WO (1) WO2021056098A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115003330A (zh) * 2019-09-23 2022-09-02 科纳克斯资本 作为疫苗和诊断工具的新糖缀合物
US20240308991A1 (en) * 2021-01-15 2024-09-19 Koranex Capital Process for the synthesis of reactive carbohydrates including antigen precursors for conjugation with a carrier material
WO2022198314A1 (en) * 2021-03-23 2022-09-29 Koranex Capital Antibodies binding to o-linked carbohydrates on sars-cov-2 spike protein and uses thereof
CN113499433B (zh) * 2021-06-21 2022-03-18 复旦大学 一种具有抗肿瘤活性的GalNAc/CpG脂质体疫苗、制备方法及应用
US20230009415A1 (en) * 2021-07-01 2023-01-12 Board Of Regents, The University Of Texas System Synthetic biomarkers for differential serological diagnosis of cutaneous leishmaniasis (cl) caused by various leishmania species
CN114306586A (zh) * 2022-01-04 2022-04-12 天津科技大学 基于tf抗原和壳寡糖内源性佐剂的肿瘤疫苗、方法和应用
CN116333062B (zh) * 2022-12-23 2025-06-17 山东大学 一种SARS-CoV-2冠状病毒糖基化RBD蛋白及其制备与应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8203925D0 (sv) * 1982-06-23 1982-06-23 Svenska Sockerfabriks Ab New and novel glycosides, glycoconjugates and processes for their preparation
WO1995029927A2 (en) 1994-05-02 1995-11-09 Biomira, Inc. Process for preparation of glycosides of tumor-associated carbohydrate antigens
JPH0851998A (ja) * 1994-08-10 1996-02-27 Otsuka Pharmaceut Co Ltd 糖転移酵素の活性測定法
EP1007541B1 (en) 1997-08-28 2006-08-23 Biomira, Inc. Randomly generated glycopeptide combinatorial libraries
DE69941574D1 (de) * 1998-08-19 2009-12-03 Baxter Healthcare Sa Immunogenes beta-propionamido-gebundenes polysaccharid-protein konjugat geeignet als impfstoff und hergestellt bei verwendung von n-acryloyliertem polysaccharid
CA2434668A1 (en) * 2003-07-04 2005-01-04 Laurence Mulard Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a
US20070275007A1 (en) 2003-11-05 2007-11-29 The Government Of The United States Of America, Represented By The Secretary Of Health And Human S Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof as Antimetastatic Agents in Treating Cancer
KR101515078B1 (ko) * 2005-12-22 2015-04-24 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신
GB201108472D0 (en) * 2011-05-19 2011-07-06 Isis Innovation HIV vaccine
WO2015006740A2 (en) 2013-07-11 2015-01-15 Alnylam Pharmaceuticals, Inc. Oligonucleotide-ligand conjugates and process for their preparation
WO2016070163A1 (en) 2014-10-31 2016-05-06 Almeida Igor C Glycoconjugates and methods for their use
WO2019178699A1 (en) * 2018-03-23 2019-09-26 Koranex Capital Precision glycoconjugates as therapeutic tools
CN110064050B (zh) * 2019-04-29 2020-10-02 北京大学 含STn或F-STn的糖缀合物及其制备方法和在抗肿瘤疫苗中的应用
CN115003330A (zh) * 2019-09-23 2022-09-02 科纳克斯资本 作为疫苗和诊断工具的新糖缀合物
WO2022198314A1 (en) * 2021-03-23 2022-09-29 Koranex Capital Antibodies binding to o-linked carbohydrates on sars-cov-2 spike protein and uses thereof

Similar Documents

Publication Publication Date Title
JP2022549292A5 (https=)
Wei et al. Carbohydrate‐based vaccines for oncotherapy
Livingston Augmenting the immunogenicity of carbohydrate tumor antigens
Feng et al. Recent advance in tumor-associated carbohydrate antigens (TACAs)-based antitumor vaccines
Ragupathi Carbohydrate antigens as targets for active specific immunotherapy
Liu et al. Carbohydrate-based cancer vaccines: target cancer with sugar bullets
Yin et al. Recent development in carbohydrate based anticancer vaccines
IL291601B1 (en) Neoglycoconjugates as vaccines and therapeutic tools
JP4754689B2 (ja) 複数種オリゴ糖の糖接合体型の細菌性髄膜炎ワクチン
Livingston et al. Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans
JP3852945B2 (ja) Qs−21を伴う、ガングリオシド‐klh複合体
Ragupathi et al. Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines
CN110064050B (zh) 含STn或F-STn的糖缀合物及其制备方法和在抗肿瘤疫苗中的应用
Ragupathi et al. A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers
Song et al. Fluorine-modified sialyl-Tn-CRM197 vaccine elicits a robust immune response
US12280109B2 (en) Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants in vaccines
RU2020131305A (ru) Прецизионные гликоконъюгаты в качестве терапевтических инструментов
WO2008031126A1 (en) Multi-component tumour vaccine
JP2002534481A (ja) 抗癌ワクチン接種のための抗体の使用
Kieber-Emmons et al. Peptide mimicry of adenocarcinoma-associated carbohydrate antigens
Helling et al. Ganglioside conjugate vaccines: Immunotherapy against tumors of neuroectodermal origin
Li et al. Design of a MUC1-based tricomponent vaccine adjuvanted with FSL-1 for cancer immunotherapy
Ritter et al. Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Campylobacter jejuni
CN104208671A (zh) 一种肺炎多价结合疫苗及其制备方法
Kim et al. Impact of minimal tumor burden on antibody response to vaccination